FI972433A0 - Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia - Google Patents

Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia

Info

Publication number
FI972433A0
FI972433A0 FI972433A FI972433A FI972433A0 FI 972433 A0 FI972433 A0 FI 972433A0 FI 972433 A FI972433 A FI 972433A FI 972433 A FI972433 A FI 972433A FI 972433 A0 FI972433 A0 FI 972433A0
Authority
FI
Finland
Prior art keywords
inflammation
fragments
treatment
compositions containing
rantes peptide
Prior art date
Application number
FI972433A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972433A (fi
Inventor
Timothy Nigel Carl Wells
Amanda Elizabeth Inn Proudfoot
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9424835.8A external-priority patent/GB9424835D0/en
Priority claimed from GBGB9512319.6A external-priority patent/GB9512319D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI972433A0 publication Critical patent/FI972433A0/fi
Publication of FI972433A publication Critical patent/FI972433A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI972433A 1994-12-08 1997-06-06 Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia FI972433A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9424835.8A GB9424835D0 (en) 1994-12-08 1994-12-08 Substances and their uses
GBGB9512319.6A GB9512319D0 (en) 1995-06-16 1995-06-16 Substances and their uses
PCT/GB1995/002861 WO1996017935A2 (en) 1994-12-08 1995-12-07 Rantes peptide and fragments and compositions comprising it for treatment of inflammation

Publications (2)

Publication Number Publication Date
FI972433A0 true FI972433A0 (fi) 1997-06-06
FI972433A FI972433A (fi) 1997-06-06

Family

ID=26306133

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972433A FI972433A (fi) 1994-12-08 1997-06-06 Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia

Country Status (15)

Country Link
US (2) US6159711A (cs)
EP (1) EP0796330A1 (cs)
JP (1) JPH10510151A (cs)
CN (1) CN1087346C (cs)
AU (1) AU688641B2 (cs)
BR (1) BR9509890A (cs)
CA (1) CA2207036A1 (cs)
CZ (1) CZ290850B6 (cs)
FI (1) FI972433A (cs)
HU (1) HU221089B1 (cs)
MX (1) MX9703889A (cs)
NO (1) NO972620L (cs)
NZ (1) NZ296570A (cs)
PL (1) PL182786B1 (cs)
WO (1) WO1996017935A2 (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9509890A (pt) * 1994-12-08 1997-12-30 Glaxo Group Ltd Polipeptídeo sequencia de dna ou rna vetor célula hospedeira e processo para produzir um polipeptídeo
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
AU4561497A (en) * 1996-09-25 1998-04-17 British Biotech Pharmaceuticals Limited Human rantes mutants incapable of aggregate formation
US6852508B1 (en) 1997-02-28 2005-02-08 Genetics Institute, Llc Chemokine with amino-terminal modifications
US6100387A (en) 1997-02-28 2000-08-08 Genetics Institute, Inc. Chimeric polypeptides containing chemokine domains
IT1291353B1 (it) * 1997-05-12 1999-01-07 San Raffaele Centro Fond Peptidi con attivita' antivirale
US6168784B1 (en) * 1997-09-03 2001-01-02 Gryphon Sciences N-terminal modifications of RANTES and methods of use
EP0906954A1 (en) * 1997-09-29 1999-04-07 Applied Research Systems ARS Holding N.V. Amino-terminal truncated c-c chemokines as chemokine antagonist
MXPA00003885A (es) * 1997-10-22 2004-04-23 Inst Genetics Llc Quimiocinas con modificiaciones de la terminacion amino.
DE69832216T2 (de) * 1997-12-23 2006-05-24 Fondazione Centro San Raffaele Del Monte Tabor RANTES-Mutanten und therapeutische Anwendungen davon
US6121023A (en) * 1998-01-22 2000-09-19 Akzo Nobel N.V. Isothermal transcription based assay for the detection and quantification of the chemokine rantes
EP1000626A1 (en) * 1998-09-18 2000-05-17 Applied Research Systems ARS Holding N.V. Chemokine receptor antagonist and cyclosporin in combined therapy
IT1303736B1 (it) * 1998-11-11 2001-02-23 San Raffaele Centro Fond Peptidi derivati da rantes con attivita' anti-hiv.
WO2000056879A1 (en) * 1999-03-22 2000-09-28 Universität Zürich TRANSFORMING GROWTH FACTOR (TFG) β SUPERFAMILY ANTAGONISTS
AU2001278905B2 (en) 2000-09-08 2004-12-16 Gryphon Therapeutics, Inc. Synthetic erythropoiesis stimulating proteins
US8153121B2 (en) * 2000-10-06 2012-04-10 Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders
US7998681B2 (en) * 2000-10-06 2011-08-16 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Diagnosis and therapy of antibody-mediated inflammatory auto-immune disorders
CA2465188A1 (en) * 2001-10-30 2003-05-08 President And Fellows Of Harvard College Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor
JP2005525089A (ja) * 2001-12-17 2005-08-25 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ ケモカイン・アンタゴニストとして作用するケモカイン突然変異体
US20040191215A1 (en) * 2003-03-25 2004-09-30 Michael Froix Compositions for induction of a therapeutic response
WO2007002465A2 (en) * 2005-06-23 2007-01-04 Rapid Pharmaceuticals, Llc Stabilizing alkylglycoside compositions and methods thereof
WO2008015199A1 (en) * 2006-07-31 2008-02-07 Laboratoires Serono S.A. Chemokine antagonists
MX2010001307A (es) * 2007-08-02 2010-07-30 Novimmune Sa Anticuerpos anti-proteína regulada con la activación, expresada y secretada por los linfocitos t normales y metodos de uso de los mismos.
AU2011213559B2 (en) 2010-02-08 2015-05-07 The Trustees Of The University Of Pennsylvania Nucleic acid molecules encoding RANTES, and compositions comprising and methods of using the same
US20140271680A1 (en) 2011-08-12 2014-09-18 Universite Paris-Est Creteil Val De Marne Methods and pharmaceutical compositions for treatment of pulmonary hypertension
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions
AU2022359841A1 (en) 2021-10-06 2024-05-02 Virothera Ltd Novel immune regulator

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9509890A (pt) * 1994-12-08 1997-12-30 Glaxo Group Ltd Polipeptídeo sequencia de dna ou rna vetor célula hospedeira e processo para produzir um polipeptídeo

Also Published As

Publication number Publication date
CZ171997A3 (en) 1997-11-12
CA2207036A1 (en) 1996-06-13
AU4120896A (en) 1996-06-26
AU688641B2 (en) 1998-03-12
WO1996017935A3 (en) 1996-08-22
NO972620L (no) 1997-08-06
JPH10510151A (ja) 1998-10-06
BR9509890A (pt) 1997-12-30
NZ296570A (en) 1998-11-25
CZ290850B6 (cs) 2002-10-16
NO972620D0 (no) 1997-06-06
FI972433A (fi) 1997-06-06
EP0796330A1 (en) 1997-09-24
CN1087346C (zh) 2002-07-10
WO1996017935A2 (en) 1996-06-13
CN1168697A (zh) 1997-12-24
PL182786B1 (pl) 2002-02-28
HUT77075A (hu) 1998-03-02
HU221089B1 (en) 2002-08-28
US6555105B1 (en) 2003-04-29
PL320565A1 (en) 1997-10-13
US6159711A (en) 2000-12-12
MX9703889A (es) 1997-08-30

Similar Documents

Publication Publication Date Title
FI972433A0 (fi) Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
BR9406178A (pt) Composição de amino-açucar e glicosaminoglicano para o tratamento e restauração de tecido conectivo
BR9407799A (pt) Composição de matéria método de tratamento e composição farmaceutica
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
BR9407869A (pt) Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose
DE69509544T2 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
IL116479A0 (en) Antifungal compositions and bandage for treatment of nails
LV11865A (lv) Kompozicijas un panemieni tuklo sunu iekaisumu arstesanai
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69607321D1 (de) Reinigungsverfahren und zusammensetzung
BR9604959A (pt) Composição e método para o tratamento de desensibilização de dentes
EP0717592A4 (en) METHOD AND COMPOSITION FOR TREATING THE APATHIE DEMOTIVATION SYNDROME
IL125446A0 (en) Pharmaceutical composition for the treatment of asthma allergy and inflammation
DE69812784D1 (de) Zusammensetzung zur Vorbeugung und Beseitigung von Pflanzenkrankheiten
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
AU4133997A (en) Pharmaceutical composition for the treatment of syndrome x of reaven
EP0727990A4 (en) CONNECTIONS, PREPARATIONS AND TREATMENT OF ALLERGIES AND IGNITIONS
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
EP0722322A4 (en) CONNECTIONS AND COMPOSITIONS FOR THE TREATMENT OF ALLERGIES AND IGNITIONS
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
AU3899893A (en) Compositions for the treatment of acute or chronic inflammation
FI961380A (fi) Koostumuksia virusten aiheuttamien kasvainten ehkäisemiseksi ja hoitamiseksi
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt

Legal Events

Date Code Title Description
MA Patent expired